このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Effect of Exercise Order During Pulmonary Rehabilitation on Muscle Strength in Patients With COPD (ISTOR-COPD)

2026年9月4日 更新者:CHU de Reims

Effect of Intra-Session Training Order of Cardiorespiratory Endurance Work and Muscle Strengthening in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD) is a chronic multisystem disease frequently associated with peripheral muscle dysfunction, which is strongly linked to prognosis and survival. Pulmonary rehabilitation is a cornerstone of COPD management and includes both cardiorespiratory endurance training and muscle strengthening exercises. Although these components are routinely combined within rehabilitation programs, the optimal order in which they should be performed during the same training session remains unclear.

In healthy individuals, performing endurance and strength exercises in different sequences within a single session may influence muscular adaptations, a phenomenon referred to as the intra session interference effect. This effect has never been studied in patients with COPD undergoing pulmonary rehabilitation. Given the high prevalence and clinical importance of muscle weakness in COPD, optimizing exercise prescription may improve functional outcomes and long term benefits.

This multicenter randomized controlled trial aims to compare two pulmonary rehabilitation strategies that differ only in the order of exercise administration. Participants with moderate to severe COPD will be randomly assigned to perform either muscle strengthening before endurance training or endurance training before muscle strengthening during each rehabilitation session.

The primary objective is to evaluate the impact of exercise order on lower limb muscle strength, assessed by the Five Times Sit to Stand test at the end of the rehabilitation program. Secondary objectives include assessment of exercise capacity, dyspnea, muscle and inflammatory biomarkers, tolerance, and adherence to the rehabilitation program, as well as follow up evaluations up to 12 months after completion.

The results of this study are expected to provide evidence to optimize pulmonary rehabilitation programs for patients with COPD and to inform clinical practice regarding exercise sequencing.

調査の概要

詳細な説明

Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory respiratory condition with systemic consequences, particularly affecting skeletal muscle structure and function. Peripheral muscle dysfunction is common in patients with COPD and is independently associated with reduced exercise capacity, impaired quality of life, increased morbidity, and mortality. Pulmonary rehabilitation is a central component of COPD management and is strongly recommended for symptomatic patients. Comprehensive pulmonary rehabilitation programs typically combine cardiorespiratory endurance training and peripheral muscle strengthening, along with ventilatory physiotherapy and therapeutic education.

While both endurance training and muscle strengthening are known to be effective, the optimal modalities for combining these interventions remain incompletely defined. In particular, the order in which endurance and strength exercises are performed during the same training session may influence physiological adaptations. In healthy populations, concurrent training studies have demonstrated an intra session interference effect, whereby endurance exercise performed prior to strength training may attenuate strength gains. Meta analyses conducted in healthy and athletic populations suggest that performing muscle strengthening before endurance training results in greater improvements in muscle strength. However, this phenomenon has never been investigated in patients with COPD, despite the high prevalence and clinical significance of muscle impairment in this population.

The ISTOR COPD study is designed to evaluate whether the intra session order of muscle strengthening and cardiorespiratory endurance training influences functional outcomes in patients undergoing pulmonary rehabilitation for COPD. This is a multicenter, randomized, controlled, superiority trial with two parallel intervention groups.

Study Design and Setting The study will be conducted in five pulmonary rehabilitation centers in France, including university hospitals and specialized rehabilitation facilities. Eligible patients admitted for pulmonary rehabilitation will be screened consecutively. Following the provision of oral and written information and the signing of informed consent, participants will be randomized in a 1:1 ratio using a centralized, computer generated allocation sequence stratified by center.

Interventions All participants will receive a standardized pulmonary rehabilitation program delivered according to international and national recommendations. The program will include three supervised rehabilitation sessions per week over an eight week period (total of 24 sessions). Each session will incorporate both peripheral muscle strengthening and cardiorespiratory endurance training, with the same total duration, intensity targets, and weekly frequency in both study arms.

The only difference between groups will be the order in which the two components are performed within each session:

  • In the first group, muscle strengthening is performed before cardiorespiratory endurance training.
  • In the second group, cardiorespiratory endurance training is performed before muscle strengthening.

A standardized rest period (≤ 1 hour) may be allowed between the two components when required by local organization.

Muscle Strengthening Muscle strengthening sessions will last 45 to 60 minutes, with a uniform duration across all participating centers, and will target both lower- and upper-limb muscle groups, with a particular focus on lower-limb muscles involved in functional mobility. The primary objective of muscle strengthening is to achieve gains in muscle strength. Training intensity will therefore be prescribed according to a strength-oriented protocol, standardized across centers and parameterized based on an indirect estimation of the one-repetition maximum (1-RM). Exercises will be performed using free weights (dumbbells), elastic resistance bands, body-weight exercises, and a leg press device. For each targeted muscle group, exercises will be conducted using 8 to 12 repetitions per set, consistent with strength-training recommendations, with systematic progression of training load to maintain an effective stimulus throughout the rehabilitation program.

Cardiorespiratory Endurance Training Endurance training sessions will last 30 to 45 minutes and will be conducted on a cycle ergometer, treadmill, or rowing ergometer, depending on patient capabilities and center equipment. Training intensity will be prescribed based on pre rehabilitation cardiopulmonary exercise testing or dyspnea thresholds. Sessions will include a warm up phase, a continuous endurance training phase at the prescribed intensity, and a recovery phase. Oxygen supplementation will be provided during exercise when clinically indicated.

Outcome Assessment Outcome assessments will be conducted by trained assessors who are independent of the rehabilitation team and blinded to group allocation. The primary outcome is lower limb muscle strength, assessed using the Five Times Sit to Stand test at the end of the rehabilitation program. This functional test is widely validated in COPD, easily applicable in routine clinical settings, and strongly associated with clinical outcomes including survival.

Secondary outcomes include repeated measurements of muscle strength, functional exercise capacity assessed by the 6 Minute Walk Test, dyspnea assessed using the modified Medical Research Council scale and the Dyspnea 12 questionnaire, and tolerance to the rehabilitation program evaluated through session adherence and fatigue scores. Exploratory biological outcomes include muscle and inflammatory biomarkers (haptoglobin and interleukin 6) measured in a subset of patients.

Participants will be followed for up to 12 months after completion of the rehabilitation program, with evaluations conducted at 3, 6, and 12 months to assess the persistence of functional benefits.

Statistical Considerations The trial is powered to detect a clinically meaningful between group difference in the Five Times Sit to Stand test at the end of rehabilitation. Analyses will be conducted primarily according to the intention to treat principle. Between group comparisons will be performed using appropriate parametric or non parametric methods, with adjustment for predefined covariates including center, age, sex, and COPD severity using multivariable regression models.

Expected Contribution This study is the first randomized controlled trial to specifically investigate the intra session exercise order effect in pulmonary rehabilitation for COPD. By isolating the impact of exercise sequencing within otherwise identical rehabilitation programs, the trial aims to provide practical evidence to optimize rehabilitation prescription. The findings may directly inform clinical practice guidelines and have broader implications for exercise based rehabilitation in other chronic respiratory, cardiovascular, and neurological diseases.

研究の種類

介入

入学 (推定)

138

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Age ≥ 18 years
  • COPD GOLD stages 2 to 4
  • Admitted for pulmonary rehabilitation in a participating center
  • Ability to read and speak French
  • Written informed consent
  • Affiliation with a social security system

Exclusion Criteria:

  • Legal protection (guardianship or trusteeship)
  • Pregnancy beyond the second trimester
  • Musculoskeletal disorders affecting lower limb strength or walking performance
  • Vascular disease limiting walking distance
  • Cardiac contraindication to pulmonary rehabilitation

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Muscle Strengthening Before Endurance Training (MS-ET)
Participants assigned to this arm will follow a standardized pulmonary rehabilitation program in which muscle strengthening exercises are systematically performed before cardiorespiratory endurance training within each rehabilitation session. The overall content, frequency, duration, and intensity of the rehabilitation program are identical to those of the comparison arm; only the intra session order of the exercise components differs. Sessions are conducted three times per week over an eight week period under professional supervision.
All participants receive the same standardized pulmonary rehabilitation program, differing only in the intra-session exercise order. Sessions are supervised, performed 3 times/week for 8 weeks and combine cardiorespiratory endurance and peripheral muscle strengthening. Endurance training consists of 30-45min continuous exercise on a cycle ergometer, treadmill or rowing ergometer, with intensity individually prescribed from baseline exercise testing and adjusted according to tolerance and dyspnea. Strength training lasts 45-60min and targets upper- and lower-limb muscles using dumbbells, elastic bands, body-weight exercises and leg press. Initial training loads are determined from indirect 1-RM estimation. After a familiarization phase, patients perform 6 alternating upper/lower-limb exercises in 3 sets of 8-12 repetitions near maximal effort, with standardized rest periods and movement tempo. Loads are progressively increased according to repetition performance and patient tolerance.
アクティブコンパレータ:Endurance Training Before Muscle Strengthening (ET-MS)
Participants assigned to this arm will follow a pulmonary rehabilitation program in which muscle strengthening exercises within each rehabilitation session is systematically performed before cardiorespiratory endurance training . The rehabilitation program is identical to that of the standardized arm in terms of content, frequency, duration, and intensity. The only difference between the two arms is the intra session order of endurance and strength exercises. Sessions are conducted three times per week over an eight week period under professional supervision.
All participants receive the same standardized pulmonary rehabilitation program, differing only in the intra-session exercise order. Sessions are supervised, performed 3 times/week for 8 weeks and combine cardiorespiratory endurance and peripheral muscle strengthening. Endurance training consists of 30-45min continuous exercise on a cycle ergometer, treadmill or rowing ergometer, with intensity individually prescribed from baseline exercise testing and adjusted according to tolerance and dyspnea. Strength training lasts 45-60min and targets upper- and lower-limb muscles using dumbbells, elastic bands, body-weight exercises and leg press. Initial training loads are determined from indirect 1-RM estimation. After a familiarization phase, patients perform 6 alternating upper/lower-limb exercises in 3 sets of 8-12 repetitions near maximal effort, with standardized rest periods and movement tempo. Loads are progressively increased according to repetition performance and patient tolerance

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Five Times Sit to Stand Test (5STS)
時間枠:End of pulmonary rehabilitation program (8 weeks)
Assessment of lower limb muscle strength using a standardized functional test There is no minimum and maximum values in this measure. The higher the score, the worse the result.
End of pulmonary rehabilitation program (8 weeks)

二次結果の測定

結果測定
メジャーの説明
時間枠
Five Times Sit to Stand Test (5STS)
時間枠:3 months after program completion
Assessment of lower limb muscle strength using a standardized functional test There is no minimum and maximum values in this measure. The higher the score, the worse the result.
3 months after program completion
Five Times Sit to Stand Test (5STS)
時間枠:6 months after program completion
Assessment of lower limb muscle strength using a standardized functional test There is no minimum and maximum values in this measure. The higher the score, the worse the result.
6 months after program completion
Five Times Sit to Stand Test (5STS)
時間枠:12 months after program completion
Assessment of lower limb muscle strength using a standardized functional test There is no minimum and maximum values in this measure. The higher the score, the worse the result.
12 months after program completion
6 Minute Walk Test (6MWT)
時間枠:End 3 months after program completion
Assessment of functional exercise capacity using a standardized submaximal walking test There is no minimum and maximum values in this measure. The higher the score, the better the result.
End 3 months after program completion
6 Minute Walk Test (6MWT)
時間枠:End 6 months after program completion
Assessment of functional exercise capacity using a standardized submaximal walking test There is no minimum and maximum values in this measure. The higher the score, the better the result.
End 6 months after program completion
6 Minute Walk Test (6MWT)
時間枠:End 12 months after program completion
Assessment of functional exercise capacity using a standardized submaximal walking test There is no minimum and maximum values in this measure. The higher the score, the better the result.
End 12 months after program completion
Dyspnea (mMRC and Dyspnea 12)
時間枠:End 3 months after program completion

Assessment of dyspnea severity using validated patient reported outcome measures For the modified Medical Resaerch Council (mMRC), the minimum value is 0 and the maximum is 4. The higher the score, the worse the result.

For Dyspnea-12 : the minimum value is 0 and the maximal is 36. The higher the score, the worse the results.

End 3 months after program completion
Dyspnea (mMRC and Dyspnea 12)
時間枠:End 6 months after program completion

Assessment of dyspnea severity using validated patient reported outcome measures For the modified Medical Resaerch Council (mMRC), the minimum value is 0 and the maximum is 4. The higher the score, the worse the result.

For Dyspnea-12 : the minimum value is 0 and the maximal is 36. The higher the score, the worse the results.

End 6 months after program completion
Dyspnea (mMRC and Dyspnea 12)
時間枠:End 12 months after program completion

Assessment of dyspnea severity using validated patient reported outcome measures For the modified Medical Resaerch Council (mMRC), the minimum value is 0 and the maximum is 4. The higher the score, the worse the result.

For Dyspnea-12 : the minimum value is 0 and the maximal is 36. The higher the score, the worse the results.

End 12 months after program completion
Muscle and Inflammatory Biomarkers (Haptoglobin)
時間枠:Baseline, 1 month, and 2 months
Assessment of muscle related and inflammatory biomarkers using blood sample analysis. It will be assessed only at the Reims center Unit of Measure: g/L
Baseline, 1 month, and 2 months
Muscle and Inflammatory Biomarkers (IL-6)
時間枠:Baseline, 1 month, and 2 months
Assessment of muscle related and inflammatory biomarkers using blood sample analysis. It will be assessed only at the Reims center Unit of Measure: pg/mL
Baseline, 1 month, and 2 months
Fatigue score as measured by Numeric Rating Scale (0-10)
時間枠:Baseline, 1 month, and 2 months

Assessment of program tolerance based on fatigue evaluation : Participants rate their fatigue on a 0-10 numeric scale at each assessment point.

Unit of Measure: 0-10

Baseline, 1 month, and 2 months
Number of completed sessions out of total planned sessions
時間枠:Baseline, 1 month, and 2 months

The total number of intervention sessions completed by each participant will be recorded and compared to the total number of sessions planned

Unit of Measure: Number of sessions

Baseline, 1 month, and 2 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年8月6日

一次修了 (推定)

2028年8月1日

研究の完了 (推定)

2030年1月1日

試験登録日

最初に提出

2026年5月20日

QC基準を満たした最初の提出物

2026年6月12日

最初の投稿 (実際)

2026年6月17日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月8日

QC基準を満たした最後の更新が送信されました

2026年9月4日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

未定

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する